HomeXBIT • NASDAQ
add
XBiotech Inc
Previous close
$2.27
Day range
$2.26 - $2.44
Year range
$2.09 - $7.64
Market cap
73.48M USD
Avg Volume
147.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.05M | -23.49% |
Net income | -6.01M | -19.80% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.62M | 24.72% |
Effective tax rate | -1.73% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 147.37M | -19.52% |
Total assets | 172.42M | -17.84% |
Total liabilities | 5.34M | -69.87% |
Total equity | 167.08M | — |
Shares outstanding | 30.49M | — |
Price to book | 0.41 | — |
Return on assets | -8.61% | — |
Return on capital | -8.89% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -6.01M | -19.80% |
Cash from operations | -4.26M | 27.13% |
Cash from investing | -110.00K | 67.46% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -5.57M | -2.94% |
Free cash flow | -3.36M | 39.41% |
About
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases. Wikipedia
Founded
2005
Headquarters
Website
Employees
88
